Medication	B:C2081612
,	O
rehabilitation	O
and	O
health	O
care	O
consumption	O
in	O
adults	O
with	O
cerebral	O
palsy	I:C0007789
:	O
A	O
population	O
based	I:C1709599
study	I:C1709599
.	O

Medication	O
,	O
rehabilitation	O
and	O
health	O
care	O
consumption	O
in	O
adults	O
with	O
cerebral	B:C0007789
palsy	I:C0007789
:	O
A	O
population	O
based	I:C1709599
study	I:C1709599
.	O

Medication	O
,	O
rehabilitation	O
and	O
health	O
care	O
consumption	O
in	O
adults	O
with	O
cerebral	O
palsy	I:C0007789
:	O
A	O
population	B:C1709599
based	I:C1709599
study	I:C1709599
.	O

To	O
evaluate	O
medication	B:C2081612
,	O
rehabilitation	O
and	O
healthcare	O
consumption	O
in	O
adults	O
with	O
CP	O
as	O
a	O
function	O
of	O
Gross	O
Motor	I:C3873236
Function	I:C3873236
Classification	I:C3873236
System	I:C3873236
(	O
Gross	O
Motor	I:C3873236
Function	I:C3873236
Classification	I:C3873236
System	I:C3873236
)	O
level	O
.	O

To	O
evaluate	O
medication	O
,	O
rehabilitation	O
and	O
healthcare	O
consumption	O
in	O
adults	O
with	O
CP	B:C0007789
as	O
a	O
function	O
of	O
Gross	O
Motor	I:C3873236
Function	I:C3873236
Classification	I:C3873236
System	I:C3873236
(	O
Gross	O
Motor	I:C3873236
Function	I:C3873236
Classification	I:C3873236
System	I:C3873236
)	O
level	O
.	O

To	O
evaluate	O
medication	O
,	O
rehabilitation	O
and	O
healthcare	O
consumption	O
in	O
adults	O
with	O
CP	O
as	O
a	O
function	O
of	O
Gross	B:C3873236
Motor	I:C3873236
Function	I:C3873236
Classification	I:C3873236
System	I:C3873236
(	O
Gross	O
Motor	I:C3873236
Function	I:C3873236
Classification	I:C3873236
System	I:C3873236
)	O
level	O
.	O

To	O
evaluate	O
medication	O
,	O
rehabilitation	O
and	O
healthcare	O
consumption	O
in	O
adults	O
with	O
CP	O
as	O
a	O
function	O
of	O
Gross	O
Motor	I:C3873236
Function	I:C3873236
Classification	I:C3873236
System	I:C3873236
(	O
Gross	B:C3873236
Motor	I:C3873236
Function	I:C3873236
Classification	I:C3873236
System	I:C3873236
)	O
level	O
.	O

Questionnaire	B:C0034394
-	O
based	O
cross-sectional	O
study	I:C0010362
.	O

Questionnaire	O
-	O
based	O
cross-sectional	B:C0010362
study	I:C0010362
.	O

Brittany	B:C0017446
,	O
a	O
French	O
county	I:C0079170
.	O

Brittany	O
,	O
a	O
French	B:C0079170
county	I:C0079170
.	O

Adults	O
with	O
cerebral	B:C0007789
palsy	I:C0007789
.	O

Questionnaires	B:C0034394
relating	O
to	O
drugs	O
,	O
orthotic	O
devices	I:C0029365
,	O
mobility	O
aids	I:C3495449
,	O
rehabilitation	O
and	O
medical	O
input	I:C0496675
were	O
sent	O
to	O
435	O
members	O
of	O
a	O
unique	O
regional	O
French	I:C0017446
network	O
dedicated	O
to	O
adults	O
with	O
cerebral	O
palsy	I:C0007789
.	O

Questionnaires	O
relating	O
to	O
drugs	B:C0013227
,	O
orthotic	O
devices	I:C0029365
,	O
mobility	O
aids	I:C3495449
,	O
rehabilitation	O
and	O
medical	O
input	I:C0496675
were	O
sent	O
to	O
435	O
members	O
of	O
a	O
unique	O
regional	O
French	I:C0017446
network	O
dedicated	O
to	O
adults	O
with	O
cerebral	O
palsy	I:C0007789
.	O

Questionnaires	O
relating	O
to	O
drugs	O
,	O
orthotic	B:C0029365
devices	I:C0029365
,	O
mobility	O
aids	I:C3495449
,	O
rehabilitation	O
and	O
medical	O
input	I:C0496675
were	O
sent	O
to	O
435	O
members	O
of	O
a	O
unique	O
regional	O
French	I:C0017446
network	O
dedicated	O
to	O
adults	O
with	O
cerebral	O
palsy	I:C0007789
.	O

Questionnaires	O
relating	O
to	O
drugs	O
,	O
orthotic	O
devices	I:C0029365
,	O
mobility	B:C3495449
aids	I:C3495449
,	O
rehabilitation	O
and	O
medical	O
input	I:C0496675
were	O
sent	O
to	O
435	O
members	O
of	O
a	O
unique	O
regional	O
French	I:C0017446
network	O
dedicated	O
to	O
adults	O
with	O
cerebral	O
palsy	I:C0007789
.	O

Questionnaires	O
relating	O
to	O
drugs	O
,	O
orthotic	O
devices	I:C0029365
,	O
mobility	O
aids	I:C3495449
,	O
rehabilitation	O
and	O
medical	B:C0496675
input	I:C0496675
were	O
sent	O
to	O
435	O
members	O
of	O
a	O
unique	O
regional	O
French	I:C0017446
network	O
dedicated	O
to	O
adults	O
with	O
cerebral	O
palsy	I:C0007789
.	O

Questionnaires	O
relating	O
to	O
drugs	O
,	O
orthotic	O
devices	I:C0029365
,	O
mobility	O
aids	I:C3495449
,	O
rehabilitation	O
and	O
medical	O
input	I:C0496675
were	O
sent	O
to	O
435	O
members	B:C0680022
of	O
a	O
unique	O
regional	O
French	I:C0017446
network	O
dedicated	O
to	O
adults	O
with	O
cerebral	O
palsy	I:C0007789
.	O

Questionnaires	O
relating	O
to	O
drugs	O
,	O
orthotic	O
devices	I:C0029365
,	O
mobility	O
aids	I:C3495449
,	O
rehabilitation	O
and	O
medical	O
input	I:C0496675
were	O
sent	O
to	O
435	O
members	O
of	O
a	O
unique	O
regional	B:C0017446
French	I:C0017446
network	O
dedicated	O
to	O
adults	O
with	O
cerebral	O
palsy	I:C0007789
.	O

Questionnaires	O
relating	O
to	O
drugs	O
,	O
orthotic	O
devices	I:C0029365
,	O
mobility	O
aids	I:C3495449
,	O
rehabilitation	O
and	O
medical	O
input	I:C0496675
were	O
sent	O
to	O
435	O
members	O
of	O
a	O
unique	O
regional	O
French	I:C0017446
network	O
dedicated	O
to	O
adults	O
with	O
cerebral	B:C0007789
palsy	I:C0007789
.	O

The	O
questionnaire	B:C0034394
was	O
completed	O
by	O
the	O
participant	O
or	O
a	O
helper	O
if	O
necessary	O
.	O

The	O
questionnaire	O
was	O
completed	O
by	O
the	O
participant	B:C0679646
or	O
a	O
helper	O
if	O
necessary	O
.	O

Of	O
the	O
282	O
responders	B:C0919876
,	O
7.8	O
%	O
had	O
a	O
GMFCS	O
level	I:C3873236
of	O
I	O
,	O
14.2	O
%	O
II	O
,	O
17.7	O
%	O
III	O
,	O
29.1	O
%	O
IV	O
and	O
31.2	O
%	O
V.	O
Participants	O
consumed	O
a	O
large	O
amount	O
of	O
healthcare	O
.	O

Of	O
the	O
282	O
responders	O
,	O
7.8	O
%	O
had	O
a	O
GMFCS	B:C3873236
level	I:C3873236
of	O
I	O
,	O
14.2	O
%	O
II	O
,	O
17.7	O
%	O
III	O
,	O
29.1	O
%	O
IV	O
and	O
31.2	O
%	O
V.	O
Participants	O
consumed	O
a	O
large	O
amount	O
of	O
healthcare	O
.	O

Of	O
the	O
282	O
responders	O
,	O
7.8	O
%	O
had	O
a	O
GMFCS	O
level	I:C3873236
of	O
I	O
,	O
14.2	O
%	O
II	O
,	O
17.7	O
%	O
III	O
,	O
29.1	O
%	O
IV	O
and	O
31.2	O
%	O
V.	O
Participants	B:C0679646
consumed	O
a	O
large	O
amount	O
of	O
healthcare	O
.	O

Almost	O
three	O
-	O
quarters	O
took	O
orally	B:C0013227
administered	I:C0013227
drugs	I:C0013227
,	O
of	O
which	O
antispastic	O
and	O
antiepileptic	O
drugs	I:C0003299
were	O
among	O
the	O
most	O
frequent	O
.	O

Almost	O
three	O
-	O
quarters	O
took	O
orally	O
administered	I:C0013227
drugs	I:C0013227
,	O
of	O
which	O
antispastic	O
and	O
antiepileptic	B:C0003299
drugs	I:C0003299
were	O
among	O
the	O
most	O
frequent	O
.	O

Nearly	O
all	O
patients	O
had	O
at	O
least	O
one	O
type	O
of	O
rehabilitation	O
,	O
87.2	O
%	O
had	O
physiotherapy	B:C0949766
,	O
78	O
%	O
used	O
at	O
least	O
one	O
mobility	O
aid	I:C3495449
and	O
69.5	O
%	O
used	O
at	O
least	O
one	O
orthotic	O
device	I:C0029365
.	O

Nearly	O
all	O
patients	O
had	O
at	O
least	O
one	O
type	O
of	O
rehabilitation	O
,	O
87.2	O
%	O
had	O
physiotherapy	O
,	O
78	O
%	O
used	O
at	O
least	O
one	O
mobility	B:C3495449
aid	I:C3495449
and	O
69.5	O
%	O
used	O
at	O
least	O
one	O
orthotic	O
device	I:C0029365
.	O

Nearly	O
all	O
patients	O
had	O
at	O
least	O
one	O
type	O
of	O
rehabilitation	O
,	O
87.2	O
%	O
had	O
physiotherapy	O
,	O
78	O
%	O
used	O
at	O
least	O
one	O
mobility	O
aid	I:C3495449
and	O
69.5	O
%	O
used	O
at	O
least	O
one	O
orthotic	B:C0029365
device	I:C0029365
.	O

The	O
frequency	O
of	O
numerous	O
inputs	O
increased	O
with	O
GMFCS	B:C3873236
level	I:C3873236
.	O

Specificities	O
were	O
found	B:C0150312
for	O
each	O
GMFCS	O
level	I:C3873236
,	O
e.g.	O
participants	O
with	O
GMFCS	O
level	I:C3873236
IV	O
and	O
V	O
had	O
a	O
high	O
level	O
of	O
medical	O
input	I:C0496675
and	O
a	O
greater	O
use	O
of	O
trunk	O
-	I:C0025080
supporting	I:C0025080
devices	I:C0025080
,	O
antireflux	O
and	O
laxative	O
.	O

Specificities	O
were	O
found	O
for	O
each	O
GMFCS	B:C3873236
level	I:C3873236
,	O
e.g.	O
participants	O
with	O
GMFCS	O
level	I:C3873236
IV	O
and	O
V	O
had	O
a	O
high	O
level	O
of	O
medical	O
input	I:C0496675
and	O
a	O
greater	O
use	O
of	O
trunk	O
-	I:C0025080
supporting	I:C0025080
devices	I:C0025080
,	O
antireflux	O
and	O
laxative	O
.	O

Specificities	O
were	O
found	O
for	O
each	O
GMFCS	O
level	I:C3873236
,	O
e.g.	O
participants	B:C0679646
with	O
GMFCS	O
level	I:C3873236
IV	O
and	O
V	O
had	O
a	O
high	O
level	O
of	O
medical	O
input	I:C0496675
and	O
a	O
greater	O
use	O
of	O
trunk	O
-	I:C0025080
supporting	I:C0025080
devices	I:C0025080
,	O
antireflux	O
and	O
laxative	O
.	O

Specificities	O
were	O
found	O
for	O
each	O
GMFCS	O
level	I:C3873236
,	O
e.g.	O
participants	O
with	O
GMFCS	B:C3873236
level	I:C3873236
IV	O
and	O
V	O
had	O
a	O
high	O
level	O
of	O
medical	O
input	I:C0496675
and	O
a	O
greater	O
use	O
of	O
trunk	O
-	I:C0025080
supporting	I:C0025080
devices	I:C0025080
,	O
antireflux	O
and	O
laxative	O
.	O

Specificities	O
were	O
found	O
for	O
each	O
GMFCS	O
level	I:C3873236
,	O
e.g.	O
participants	O
with	O
GMFCS	O
level	I:C3873236
IV	O
and	O
V	O
had	O
a	O
high	O
level	O
of	O
medical	B:C0496675
input	I:C0496675
and	O
a	O
greater	O
use	O
of	O
trunk	O
-	I:C0025080
supporting	I:C0025080
devices	I:C0025080
,	O
antireflux	O
and	O
laxative	O
.	O

Specificities	O
were	O
found	O
for	O
each	O
GMFCS	O
level	I:C3873236
,	O
e.g.	O
participants	O
with	O
GMFCS	O
level	I:C3873236
IV	O
and	O
V	O
had	O
a	O
high	O
level	O
of	O
medical	O
input	I:C0496675
and	O
a	O
greater	O
use	O
of	O
trunk	B:C0025080
-	I:C0025080
supporting	I:C0025080
devices	I:C0025080
,	O
antireflux	O
and	O
laxative	O
.	O

Specificities	O
were	O
found	O
for	O
each	O
GMFCS	O
level	I:C3873236
,	O
e.g.	O
participants	O
with	O
GMFCS	O
level	I:C3873236
IV	O
and	O
V	O
had	O
a	O
high	O
level	O
of	O
medical	O
input	I:C0496675
and	O
a	O
greater	O
use	O
of	O
trunk	O
-	I:C0025080
supporting	I:C0025080
devices	I:C0025080
,	O
antireflux	B:C0399651
and	O
laxative	O
.	O

Specificities	O
were	O
found	O
for	O
each	O
GMFCS	O
level	I:C3873236
,	O
e.g.	O
participants	O
with	O
GMFCS	O
level	I:C3873236
IV	O
and	O
V	O
had	O
a	O
high	O
level	O
of	O
medical	O
input	I:C0496675
and	O
a	O
greater	O
use	O
of	O
trunk	O
-	I:C0025080
supporting	I:C0025080
devices	I:C0025080
,	O
antireflux	O
and	O
laxative	B:C0282090
.	O

Profiles	O
could	O
be	O
established	O
based	O
on	O
GMFCS	B:C3873236
levels	I:C3873236
.	O

Adults	O
with	O
cerebral	B:C0007789
palsy	I:C0007789
use	O
a	O
large	O
amount	O
of	O
drugs	O
,	O
mobility	O
aids	I:C3495449
,	O
orthotic	O
devices	I:C0029365
,	O
rehabilitation	O
and	O
medical	O
input	I:C0496675
.	O

Adults	O
with	O
cerebral	O
palsy	I:C0007789
use	O
a	O
large	O
amount	O
of	O
drugs	B:C0013227
,	O
mobility	O
aids	I:C3495449
,	O
orthotic	O
devices	I:C0029365
,	O
rehabilitation	O
and	O
medical	O
input	I:C0496675
.	O

Adults	O
with	O
cerebral	O
palsy	I:C0007789
use	O
a	O
large	O
amount	O
of	O
drugs	O
,	O
mobility	B:C3495449
aids	I:C3495449
,	O
orthotic	O
devices	I:C0029365
,	O
rehabilitation	O
and	O
medical	O
input	I:C0496675
.	O

Adults	O
with	O
cerebral	O
palsy	I:C0007789
use	O
a	O
large	O
amount	O
of	O
drugs	O
,	O
mobility	O
aids	I:C3495449
,	O
orthotic	B:C0029365
devices	I:C0029365
,	O
rehabilitation	O
and	O
medical	O
input	I:C0496675
.	O

Adults	O
with	O
cerebral	O
palsy	I:C0007789
use	O
a	O
large	O
amount	O
of	O
drugs	O
,	O
mobility	O
aids	I:C3495449
,	O
orthotic	O
devices	I:C0029365
,	O
rehabilitation	O
and	O
medical	B:C0496675
input	I:C0496675
.	O

Healthcare	B:C0086388
is	O
targeted	O
at	O
cerebral	O
palsy	I:C0033213
-	I:C0033213
related	I:C0033213
issues	I:C0033213
.	O

Healthcare	O
is	O
targeted	O
at	O
cerebral	B:C0033213
palsy	I:C0033213
-	I:C0033213
related	I:C0033213
issues	I:C0033213
.	O

Gross	B:C3873236
Motor	I:C3873236
Function	I:C3873236
Classification	I:C3873236
System	I:C3873236
is	O
a	O
determinant	O
of	O
healthcare	O
consumption	O
and	O
thus	O
a	O
useful	O
tool	O
for	O
clinical	O
practice	O
to	O
target	O
care	O
appropriately	O
.	O

